Dan Clutter has become vice president of commercial development at Gentel Biosciences. Prior to joining the company, he held sales, marketing, and business development positions at PerkinElmer, Invitrogen, Roche, Celera, PanVera, Asterand, and NimbleGen.
Eric Winzer has joined the board of directors of Cytomedix, where he will also serve as audit committee chairman and audit committee financial expert. He is the executive vice president and chief financial officer of Avalon Pharmaceuticals. Prior to joining Avalon, he was senior vice president and chief financial officer of Invitrogen. Winzer holds an MBA from Mount Saint Mary’s University and a BA in economics and business administration from McDaniel College.